The GSN Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma epithelial cell line. This heterogeneous pool of cells carries targeted disruption of the GSN gene, which encodes the actin-binding protein gelsolin. The polyclonal format preserves diverse editing outcomes, facilitating robust functional analyses without clonal selection bias. This model supports detailed investigation of gelsolin-dependent processes in a pulmonary epithelial context.
The A-549 host cell line was originally established from the lung adenocarcinoma of a 58-year-old Caucasian male. These adherent epithelial cells serve as a widely used model for alveolar type II pulmonary epithelium, retaining key features of lung adenocarcinoma. Their well-characterized growth properties and established utility in cancer biology and toxicology research make A-549 cells an appropriate platform for studying cytoskeletal regulators in lung cancer progression and pulmonary epithelial function.
Gelsolin (GSN) is a calcium-dependent actin filament severing and capping protein that critically modulates cytoskeletal dynamics. GSN is activated by elevated intracellular Ca2? levels and inhibited by phosphatidylinositol 4,5-bisphosphate (PIP2) at the plasma membrane. During apoptosis, GSN is cleaved by caspase-3, generating a fragment that severs actin filaments independently of calcium. The gelsolin gene is also transcriptionally regulated by p53, linking actin remodeling to tumor suppression pathways. GSN interacts directly with G-actin and F-actin, and its activity is modulated by tropomyosin, thereby governing actin polymerization dynamics, cell morphology, and motility.
In A-549 cells, GSN knockout disrupts calcium-activated actin filament severing and capping, leading to altered cytoskeletal architecture and impaired cell migration and invasion??processes central to lung cancer metastasis. Loss of gelsolin function also modulates apoptosis signaling pathways, potentially affecting chemosensitivity and cell survival. As GSN is implicated in familial amyloidosis, Finnish type, and inflammatory disorders, this knockout model provides a relevant cellular context to dissect the role of actin remodeling in disease pathogenesis. The polyclonal population allows assessment of phenotypic variation arising from heterogeneous gene disruption.
Typical research applications include investigation of actin cytoskeleton regulation through immunofluorescence and live-cell imaging, cancer cell migration and invasion studies using transwell assays, and apoptosis mechanism research employing caspase activity assays. This reagent also supports high-throughput screening for cytoskeleton-targeting drugs and functional genomics of actin-binding proteins. Representative assays include Western blotting for gelsolin, actin polymerization assays, co-immunoprecipitation of actin-binding partners, and flow cytometry for F-actin content. For further information or technical support, please contact Ascent Research.
